KMT2A and leukemia: To evaluate the potential therapeutic effects of the ASH1L inhibitors, we performed an in vivo study with AS-99 using a xenotransplantation model of MLL leukemia with MV4;11 cells expressing luciferase transplanted into NSG mice29.